Dermatology RCM & Billing Services

Common Review Areas

Coding, documentation or medical-necessity gaps can lead to denials, rework or payment delays.

• Medical versus cosmetic service distinctions
• Lesion coding
• Pathology-related billing
• Medical necessity
• Documentation and modifier errors

How BlueBird Medserv Helps

We review coding and documentation patterns, assess recurring medical-necessity denials, and identify gaps between documented services, charges submitted and payments received.

Findings become a prioritized list of corrective actions, so the practice can address the process behind repeat delays and not only the individual claim. Examples on this page are illustrative; payer requirements, contracts and outcomes vary, and no financial outcome is guaranteed.

Medical versus Cosmetic Services

Dermatology blends medically necessary care with services many plans treat as cosmetic. Removal of a lesion that is symptomatic, changing or suspicious is typically medical. Removal for appearance alone usually is not covered and may be a patient-pay service. The documentation, the diagnosis and the way the patient was informed before the service all decide how the claim is handled.

Where a service may not be covered, a written financial notice before the visit protects both the patient relationship and the practice. Requirements differ for Medicare and commercial plans.

• Document symptoms or clinical concern (for example bleeding, pain, rapid change)
• Link the diagnosis to the service performed
• Capture patient acknowledgment for services that may be non-covered
• Keep cosmetic and medical services clearly separate on the claim

Lesion Coding: Biopsy, Destruction and Excision

Lesion services are coded by method, lesion type, number and, for excisions, size and anatomic site. Representative families include skin biopsy (such as 11102 and 11103 for tangential biopsy, first and each additional lesion), destruction of premalignant lesions (17000, 17003, 17004), destruction of benign lesions (17110, 17111), shave removal (11300 series) and excision of benign (11400 series) or malignant (11600 series) lesions.

Excision codes depend on the lesion's excised diameter including margins and, for benign versus malignant, on the pathology result. Claims therefore often cannot be finalized until the pathology report is back, and a charge entered from the visit note alone is a common source of recoding and denials.

Modifier 25, Multiple Lesions and Bundling

Evaluation and management on the same day as a procedure generally requires modifier 25 and a note that shows the visit was significant and separately identifiable. Distinct procedures on different lesions may need a distinct-procedure modifier (such as 59 or an X modifier) depending on the payer's edits. Payers audit modifier 25 use closely, so documentation quality matters.

Mohs Surgery, Pathology and Biologics

Mohs micrographic surgery is coded by stage and site and generally requires documentation that the surgeon acted as both surgeon and pathologist, along with medical-necessity criteria that many payers apply. Practices with an in-house dermatopathology lab have additional laboratory billing and compliance requirements.

Biologic and other specialty drugs for conditions such as psoriasis commonly need prior authorization, and drug claims depend on accurate product, units and diagnosis.

Common Dermatology Denial Reasons and Where to Look

Codes, modifiers and payer rules change, and payers differ. Treat the examples below as orientation and verify against the current CPT/HCPCS code set and each payer's policy.

Where to Start

Begin with a review of your recent denials, payment variances and outstanding claims for dermatology. See also our RCM Audit & Revenue Leakage Assessment, Denial Management and Insurance Eligibility & Verification services.